Literature DB >> 25688083

Early behavioural changes in familial Alzheimer's disease in the Dominantly Inherited Alzheimer Network.

John M Ringman1, Li-Jung Liang2, Yan Zhou3, Sitaram Vangala2, Edmond Teng4, Sarah Kremen3, David Wharton3, Alison Goate5, Daniel S Marcus6, Martin Farlow7, Bernardino Ghetti8, Eric McDade9, Colin L Masters10, Richard P Mayeux11, Martin Rossor12, Stephen Salloway13, Peter R Schofield14, Jeffrey L Cummings15, Virginia Buckles6, Randall Bateman6, John C Morris6.   

Abstract

Prior studies indicate psychiatric symptoms such as depression, apathy and anxiety are risk factors for or prodromal symptoms of incipient Alzheimer's disease. The study of persons at 50% risk for inheriting autosomal dominant Alzheimer's disease mutations allows characterization of these symptoms before progressive decline in a population destined to develop illness. We sought to characterize early behavioural features in carriers of autosomal dominant Alzheimer's disease mutations. Two hundred and sixty-one persons unaware of their mutation status enrolled in the Dominantly Inherited Alzheimer Network, a study of persons with or at-risk for autosomal dominant Alzheimer's disease, were evaluated with the Neuropsychiatric Inventory-Questionnaire, the 15-item Geriatric Depression Scale and the Clinical Dementia Rating Scale (CDR). Ninety-seven asymptomatic (CDR = 0), 25 mildly symptomatic (CDR = 0.5), and 33 overtly affected (CDR > 0.5) autosomal dominant Alzheimer's disease mutation carriers were compared to 106 non-carriers with regard to frequency of behavioural symptoms on the Neuropsychiatric Inventory-Questionnaire and severity of depressive symptoms on the Geriatric Depression Scale using generalized linear regression models with appropriate distributions and link functions. Results from the adjusted analyses indicated that depressive symptoms on the Neuropsychiatric Inventory-Questionnaire were less common in cognitively asymptomatic mutation carriers than in non-carriers (5% versus 17%, P = 0.014) and the odds of experiencing at least one behavioural sign in cognitively asymptomatic mutation carriers was lower than in non-carriers (odds ratio = 0.50, 95% confidence interval: 0.26-0.98, P = 0.042). Depression (56% versus 17%, P = 0.0003), apathy (40% versus 4%, P < 0.0001), disinhibition (16% versus 2%, P = 0.009), irritability (48% versus 9%, P = 0.0001), sleep changes (28% versus 7%, P = 0.003), and agitation (24% versus 6%, P = 0.008) were more common and the degree of self-rated depression more severe (mean Geriatric Depression Scale score of 2.8 versus 1.4, P = 0.006) in mildly symptomatic mutation carriers relative to non-carriers. Anxiety, appetite changes, delusions, and repetitive motor activity were additionally more common in overtly impaired mutation carriers. Similar to studies of late-onset Alzheimer's disease, we demonstrated increased rates of depression, apathy, and other behavioural symptoms in the mildly symptomatic, prodromal phase of autosomal dominant Alzheimer's disease that increased with disease severity. We did not identify any increased psychopathology in mutation carriers over non-carriers during the presymptomatic stage, suggesting these symptoms result when a threshold of neurodegeneration is reached rather than as life-long qualities. Unexpectedly, we found lower rates of depressive symptoms in cognitively asymptomatic mutation carriers.
© The Author (2015). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Alzheimer; behaviour; depression; familial; prodromal

Mesh:

Year:  2015        PMID: 25688083      PMCID: PMC4963801          DOI: 10.1093/brain/awv004

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  37 in total

1.  Neuropathologic correlates of apathy in Alzheimer's disease.

Authors:  Gad A Marshall; Lynn A Fairbanks; Sibel Tekin; Harry V Vinters; Jeffrey L Cummings
Journal:  Dement Geriatr Cogn Disord       Date:  2006-01-02       Impact factor: 2.959

2.  Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutation.

Authors:  John M Ringman; Karen H Gylys; Luis D Medina; Michelle Fox; Vladimir Kepe; Deborah L Flores; Liana G Apostolova; Jorge R Barrio; Gary Small; Daniel H Silverman; Erin Siu; Stephen Cederbaum; Silva Hecimovic; Martina Malnar; Suma Chakraverty; Alison M Goate; Thomas D Bird; James B Leverenz
Journal:  Neurosci Lett       Date:  2010-11-19       Impact factor: 3.046

3.  Neuropsychiatric symptoms in Alzheimer's disease.

Authors:  Constantine G Lyketsos; Maria C Carrillo; J Michael Ryan; Ara S Khachaturian; Paula Trzepacz; Joan Amatniek; Jesse Cedarbaum; Robert Brashear; David S Miller
Journal:  Alzheimers Dement       Date:  2011-09       Impact factor: 21.566

4.  Neuropsychiatric symptoms in mild cognitive impairment: differences by subtype and progression to dementia.

Authors:  Emily R Edwards; Adam P Spira; Deborah E Barnes; Kristine Yaffe
Journal:  Int J Geriatr Psychiatry       Date:  2009-07       Impact factor: 3.485

5.  The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.

Authors:  J L Cummings; M Mega; K Gray; S Rosenberg-Thompson; D A Carusi; J Gornbein
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

6.  Female preclinical presenilin-1 mutation carriers unaware of their genetic status have higher levels of depression than their non-mutation carrying kin.

Authors:  J M Ringman; C Diaz-Olavarrieta; Y Rodriguez; M Chavez; F Paz; J Murrell; M Angel Macias; M Hill; C Kawas
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

7.  Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.

Authors:  Hélène Amieva; Mélanie Le Goff; Xavier Millet; Jean Marc Orgogozo; Karine Pérès; Pascale Barberger-Gateau; Hélène Jacqmin-Gadda; Jean François Dartigues
Journal:  Ann Neurol       Date:  2008-11       Impact factor: 10.422

8.  Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network.

Authors:  John C Morris; Paul S Aisen; Randall J Bateman; Tammie L S Benzinger; Nigel J Cairns; Anne M Fagan; Bernardino Ghetti; Alison M Goate; David M Holtzman; William E Klunk; Eric McDade; Daniel S Marcus; Ralph N Martins; Colin L Masters; Richard Mayeux; Angela Oliver; Kimberly Quaid; John M Ringman; Martin N Rossor; Stephen Salloway; Peter R Schofield; Natalie J Selsor; Reisa A Sperling; Michael W Weiner; Chengjie Xiong; Krista L Moulder; Virginia D Buckles
Journal:  Clin Investig (Lond)       Date:  2012-10-01

Review 9.  Neuropsychiatric manifestations in mild cognitive impairment: a systematic review of the literature.

Authors:  Liana G Apostolova; Jeffrey L Cummings
Journal:  Dement Geriatr Cogn Disord       Date:  2007-12-14       Impact factor: 2.959

10.  Donepezil delays progression to AD in MCI subjects with depressive symptoms.

Authors:  P H Lu; S D Edland; E Teng; K Tingus; R C Petersen; J L Cummings
Journal:  Neurology       Date:  2009-06-16       Impact factor: 9.910

View more
  32 in total

1.  Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease.

Authors:  Eric McDade; Guoqiao Wang; Brian A Gordon; Jason Hassenstab; Tammie L S Benzinger; Virginia Buckles; Anne M Fagan; David M Holtzman; Nigel J Cairns; Alison M Goate; Daniel S Marcus; John C Morris; Katrina Paumier; Chengjie Xiong; Ricardo Allegri; Sarah B Berman; William Klunk; James Noble; John Ringman; Bernardino Ghetti; Martin Farlow; Reisa A Sperling; Jasmeer Chhatwal; Stephen Salloway; Neill R Graff-Radford; Peter R Schofield; Colin Masters; Martin N Rossor; Nick C Fox; Johannes Levin; Mathias Jucker; Randall J Bateman
Journal:  Neurology       Date:  2018-09-14       Impact factor: 9.910

Review 2.  Neuropsychiatric Symptoms in Mild Cognitive Impairment.

Authors:  Damien Gallagher; Corinne E Fischer; Andrea Iaboni
Journal:  Can J Psychiatry       Date:  2017-03       Impact factor: 4.356

3.  Suicidal ideation is common in autosomal dominant Alzheimer's disease at-risk persons.

Authors:  Kok Pin Ng; Stéphane Richard-Devantoy; Josie-Anne Bertrand; Lai Jiang; Tharick A Pascoal; Sulantha Mathotaarachchi; Joseph Therriault; Chathuri Yatawara; Nagaendran Kandiah; Celia M T Greenwood; Pedro Rosa-Neto; Serge Gauthier
Journal:  Int J Geriatr Psychiatry       Date:  2019-10-22       Impact factor: 3.485

4.  Psychiatric symptoms in preclinical behavioural-variant frontotemporal dementia in MAPT mutation carriers.

Authors:  Gayathri Cheran; Hannah Silverman; Masood Manoochehri; Jill Goldman; Seonjoo Lee; Liwen Wu; Sarah Cines; Emer Fallon; Brendan Desmond Kelly; Diana Angelika Olszewska; Judith Heidebrink; Sarah Shair; Stephen Campbell; Henry Paulson; Timothy Lynch; Stephanie Cosentino; Edward D Huey
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-01-20       Impact factor: 10.154

5.  Autosomal Dominantly Inherited Alzheimer Disease: Analysis of genetic subgroups by Machine Learning.

Authors:  Diego Castillo-Barnes; Li Su; Javier Ramírez; Diego Salas-Gonzalez; Francisco J Martinez-Murcia; Ignacio A Illan; Fermin Segovia; Andres Ortiz; Carlos Cruchaga; Martin R Farlow; Chengjie Xiong; Neil R Graff-Radford; Peter R Schofield; Colin L Masters; Stephen Salloway; Mathias Jucker; Hiroshi Mori; Johannes Levin; Juan M Gorriz
Journal:  Inf Fusion       Date:  2020-01-07       Impact factor: 12.975

6.  Widespread white matter and conduction defects in PSEN1-related spastic paraparesis.

Authors:  Steffan K Soosman; Nelly Joseph-Mathurin; Meredith N Braskie; Yvette M Bordelon; David Wharton; Maria Casado; Giovanni Coppola; Holly McCallum; Marc Nuwer; Pedro Coutin-Churchman; Liana G Apostolova; Tammie Benzinger; John M Ringman
Journal:  Neurobiol Aging       Date:  2016-08-08       Impact factor: 4.673

7.  Intermittent Hypoxia Activates N-Methyl-D-Aspartate Receptors to Induce Anxiety Behaviors in a Mouse Model of Sleep-Associated Apnea.

Authors:  Yun Fan; Mei-Chuan Chou; Yen-Chin Liu; Ching-Kuan Liu; Chu-Huang Chen; Shiou-Lan Chen
Journal:  Mol Neurobiol       Date:  2021-03-04       Impact factor: 5.590

8.  Behavioural Phenotyping of APPswe/PS1δE9 Mice: Age-Rrelated Changes and Effect of Long-Term Paroxetine Treatment.

Authors:  Louise Ørum Olesen; Elena V Bouzinova; Maurizio Severino; Mithula Sivasaravanaparan; Jørgen Bo Hasselstrøm; Bente Finsen; Ove Wiborg
Journal:  PLoS One       Date:  2016-11-04       Impact factor: 3.240

9.  Amyloid and Tau Pathology Associations With Personality Traits, Neuropsychiatric Symptoms, and Cognitive Lifestyle in the Preclinical Phases of Sporadic and Autosomal Dominant Alzheimer's Disease.

Authors:  Alexa Pichet Binette; Étienne Vachon-Presseau; John Morris; Randall Bateman; Tammie Benzinger; D Louis Collins; Judes Poirier; John C S Breitner; Sylvia Villeneuve
Journal:  Biol Psychiatry       Date:  2020-02-06       Impact factor: 13.382

10.  Early symptoms in symptomatic and preclinical genetic frontotemporal lobar degeneration.

Authors:  Tamara Paulo Tavares; Derek G V Mitchell; Kristy Kl Coleman; Brenda L Coleman; Christen L Shoesmith; Christopher R Butler; Isabel Santana; Adrian Danek; Alexander Gerhard; Alexandre de Mendonca; Barbara Borroni; Maria Carmela Tartaglia; Caroline Graff; Daniela Galimberti; Fabrizio Tagliavini; Fermin Moreno; Giovanni Frisoni; James Benedict Rowe; Johannes Levin; John Cornelis Van Swieten; Markus Otto; Matthis Synofzik; Raquel Sanchez-Valle; Rik Vandenberghe; Robert Jr Laforce; Roberta Ghidoni; Sandro Sorbi; Simon Ducharme; Mario Masellis; Jonathan Rohrer; Elizabeth Finger
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-08-07       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.